Perspective Therapeutics (CATX) Other Accumulated Expenses (2016 - 2023)

Perspective Therapeutics (CATX) has disclosed Other Accumulated Expenses for 13 consecutive years, with $480000.0 as the latest value for Q4 2023.

  • Quarterly Other Accumulated Expenses fell 15.94% to $480000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $480000.0 through Dec 2023, down 15.94% year-over-year, with the annual reading at $480000.0 for FY2023, 15.94% down from the prior year.
  • Other Accumulated Expenses hit $480000.0 in Q4 2023 for Perspective Therapeutics, up from $24000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $571000.0 in Q4 2022 to a low of $15000.0 in Q1 2023.
  • Historically, Other Accumulated Expenses has averaged $127300.0 across 5 years, with a median of $96500.0 in 2020.
  • Biggest five-year swings in Other Accumulated Expenses: surged 454.37% in 2022 and later crashed 84.04% in 2023.
  • Year by year, Other Accumulated Expenses stood at $89000.0 in 2019, then grew by 13.48% to $101000.0 in 2020, then grew by 1.98% to $103000.0 in 2021, then soared by 454.37% to $571000.0 in 2022, then dropped by 15.94% to $480000.0 in 2023.
  • Business Quant data shows Other Accumulated Expenses for CATX at $480000.0 in Q4 2023, $24000.0 in Q3 2023, and $20000.0 in Q2 2023.